90856331 - WILK

Information

• Trademark
• 90856331

• Source

• Serial Number

  90856331

• Registration Number

  7289341

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 29 - Meat, fish, poultry and game
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 29, 2021
  3 years ago

• Registration Date

  January 23, 2024
  a year ago

• Transaction Date

  January 23, 2024
  a year ago

• Status Date

  January 23, 2024
  a year ago

• Location Date

  January 23, 2024
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  DUBIN, DAVID I

• Attorney Docket Number

  122617549297

  Attorney Name

  Rebecca Liebowitz

  Law Office Assigned Location Code

  L70

• Owners

  • Biomilk Ltd.

Case File Statements

• GS0291: Cell-based cultured milk; cell-based cultured milk products excluding ice cream, namely, cultured milk; cell-based cultured cow's milk and cow's milk products excluding ice cream, namely, cultured milk; cell-based cultured sheep milk and sheep milk products excluding ice cream, namely, cultured milk; cell-based cultured goat milk and goat milk products excluding ice cream, namely, cultured milk; cell-based cultured camel milk and camel milk products excluding ice cream, namely, cultured milk; cell-based cultured buffalo milk and buffalo milk products excluding ice cream, namely, cultured milk
• N00000: The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
• GS0051: Nutraceuticals for medical purposes for the treatment of illness and medical conditions in high risk pre-term newborns, and gut and intestine colitis for patients; nutraceuticals for use as a dietary supplement; biotechnological preparations containing cell-based cultured milk for medical purposes, namely, milk ferments for pharmaceutical purposes and probiotic milk ferments in the nature of milk ferments for pharmaceutical purposes; milk ferments for pharmaceutical purposes; food for babies and infants; cell-based cultured milk formula for babies, namely, cell cultured human breast milk; oligosaccharides, namely, human milk oligosaccharides being food for infants in the nature of human breast milk
• GS0031: Cosmetic products which contain cell-based cultured milk components, namely, cosmetic creams, hair dyes and Basma dyes for cosmetic purposes, lotions for cosmetic purposes, gels for cosmetic purposes, cosmetic masks, cosmetic pads, cosmetic soaps, hair care preparations; cosmetic preparations for skin care; make-up
• GS0011: Biotechnological preparations for use in industry, namely, chemicals for use in biotechnological manufacturing processes being biotechnological preparations containing cell-based cultured milk for use in the cosmetics industry; biotechnological preparations for use in industry, namely, chemicals for use in biotechnological manufacturing processes being biotechnological preparations containing cell-based cultured milk for use in the food industry; carbohydrates used as an ingredient in the manufacture of nutraceuticals; oligosaccharides as raw materials being human milk oligosaccharides, namely, chemical additives for use in the manufacture of foods; milk ferments for the food industry; proteins for use in the manufacture of food and beverages; proteins used in the manufacture of food supplements; proteins for use in the manufacture of cosmetics; cell-based cultured milk lipids for use in manufacture of food products and beverages; cell-based cultured milk lipids for use in manufacture of food supplements; cell-based cultured milk lipids for use in manufacture of cosmetics
• GS0421: Research and development services in the field of biotechnology; biotechnological research and development relating to cell-based cultured milk; biotechnological research and development relating to cell-based cultured milk for the medical industry; biotechnological research and development relating to cell-based cultured milk for the food industry; biotechnological research and development relating to cell-based cultured milk for the cosmetics industry; product development for others in the field of biotechnology; biotechnological product development in the field of cell-based cultured milk

Case File Event Statements

• 1/23/2024 - a year ago

  38 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCS

• 1/23/2024 - a year ago

  37 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCS

• 1/23/2024 - a year ago

  36 - REGISTERED-SUPPLEMENTAL REGISTER Type: R.SR

• 10/1/2023 - a year ago

  35 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA

• 9/8/2023 - a year ago

  34 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/8/2023 - a year ago

  33 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/8/2023 - a year ago

  32 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/8/2023 - a year ago

  31 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/9/2023 - a year ago

  30 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1

• 6/9/2023 - a year ago

  29 - SUBSEQUENT FINAL EMAILED Type: GNSF

• 6/9/2023 - a year ago

  28 - SUBSEQUENT FINAL REFUSAL WRITTEN Type: CFRC

• 6/7/2023 - a year ago

  27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/6/2023 - a year ago

  26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/6/2023 - a year ago

  25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/9/2023 - a year ago

  24 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 3/9/2023 - a year ago

  23 - PRIORITY ACTION E-MAILED Type: GPRA

• 3/9/2023 - a year ago

  22 - PRIORITY ACTION WRITTEN Type: CPRA

• 3/9/2023 - a year ago

  21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/9/2023 - a year ago

  20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/9/2023 - a year ago

  19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/9/2023 - a year ago

  18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/6/2023 - a year ago

  17 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 3/6/2023 - a year ago

  16 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 12/6/2022 - 2 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 12/6/2022 - 2 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 12/6/2022 - 2 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 10/24/2022 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/24/2022 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/21/2022 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/29/2022 - 2 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/29/2022 - 2 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/29/2022 - 2 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/26/2022 - 2 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 10/5/2021 - 3 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 10/4/2021 - 3 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 8/3/2021 - 3 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 9/27/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/2/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP